REQUEST PRICE

Fields with * are required
Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

Nociceptin/Orphanin FQ Receptor Antibodies

Close filters
No results were found for the filter!
Citations
Agonist-induced Serine346 phosphorylation of the Nociceptin/Orphanin FQ Receptor.
pS346-NOP (phospho-Nociceptin/Orphanin FQ...
Serine346 (S346) is a major phosphorylation site of the nociceptin/orphanin FQ peptide receptor (NFQ receptor, NOP). The pS346-NOP antibody detects phosphorylation in response to agonists as well as after PKC activation. S346...
$ 350.00
Citations
Agonist-induced Serine351 phosphorylation of the Nociceptin/Orphanin FQ Receptor.
pS351-NOP (phospho-Nociceptin/Orphanin FQ...
Serine351 (S351) is a major phosphorylation site of the nociceptin/orphanin FQ peptide receptor (NFQ receptor, NOP). The pS351-NOP antibody detects phosphorylation in response to agonists as well as after PKC activation. S351...
$ 350.00
Citations
Agonist-induced Threonine362/Serine363 phosphorylation of the Nociceptin/Orphanin FQ Receptor.
pT362/pS363-NOP (phospho-Nociceptin/Orphanin FQ...
Threonine362/Serine363 (T362/S363) is a major phosphorylation site of the nociceptin/orphanin FQ peptide receptor (NFQ receptor, NOP). The pT362/pS363-NOP antibody detects phosphorylation in response to agonists but not after PKC...
$ 350.00
Citations
KO-Validated
Validation of the Nociceptin/Orphanin FQ Receptor in transfected HEK293 cells.
NOP (non-phospho), Nociceptin/Orphanin FQ...
The non-phospho-NFQ receptor (NOP) antibody is directed against the distal end of the carboxyl-terminal tail of mouse, rat and human NOP. In can be used to detect total MOP receptors in Western blots independent of phosphorylation. The...
$ 250.00

NOPgDAKoGzAvFpzY

The nociceptin/orphanin FQ receptor (NFQ receptor, NOP) is the fourth discovered member of the opioid receptor family. Bifunctional agonists that target NOP and MOP such as cebranopadol or AT-121 are under active investigation as novel analgesics with fewer side effects. NOP desensitization, trafficking and signaling are regulated by phosphorylation of carboxyl-terminal serine346 (pS346-NOP), serine351 (pS351-NOP) and threonine362/serine363 (pT362/pS363-NOP) residues. Agonist-induced NOP phosphorylation is predominantly mediated by GRK2 and GRK3. S346 and S351 are also substrates for PKC-mediated phosphorylation. The nomenclature refers to the human NOP. This phosphorylation motif is also present in mice and rats. For more information on NFQ receptor pharmacology please refer to the IUPHAR database. For further reading refer to:

Mann A, Moulédous L, Froment C, O'Neill PR, Dasgupta P, Günther T, Brunori G, Kieffer BL, Toll L, Bruchas MR, Zaveri NT, Schulz S. Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists. Sci Signal. 2019 Mar 26;12(574). pii: eaau8072. doi: 10.1126/scisignal.aau8072. PubMed PMID: 30914485; PubMed Central PMCID: PMC6934085.

Toll L, Bruchas MR, Calo' G, Cox BM, Zaveri NT. Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems. Pharmacol Rev. 2016 Apr;68(2):419-57. doi: 10.1124/pr.114.009209. Epub 2016 Mar 8. Review. PubMed PMID: 26956246; PubMed Central PMCID: PMC4813427.

The nociceptin/orphanin FQ receptor (NFQ receptor, NOP) is the fourth discovered member of the opioid receptor family. Bifunctional agonists that target NOP and MOP such as cebranopadol or... read more »
Close window
Nociceptin/Orphanin FQ Receptor Antibodies

NOPgDAKoGzAvFpzY

The nociceptin/orphanin FQ receptor (NFQ receptor, NOP) is the fourth discovered member of the opioid receptor family. Bifunctional agonists that target NOP and MOP such as cebranopadol or AT-121 are under active investigation as novel analgesics with fewer side effects. NOP desensitization, trafficking and signaling are regulated by phosphorylation of carboxyl-terminal serine346 (pS346-NOP), serine351 (pS351-NOP) and threonine362/serine363 (pT362/pS363-NOP) residues. Agonist-induced NOP phosphorylation is predominantly mediated by GRK2 and GRK3. S346 and S351 are also substrates for PKC-mediated phosphorylation. The nomenclature refers to the human NOP. This phosphorylation motif is also present in mice and rats. For more information on NFQ receptor pharmacology please refer to the IUPHAR database. For further reading refer to:

Mann A, Moulédous L, Froment C, O'Neill PR, Dasgupta P, Günther T, Brunori G, Kieffer BL, Toll L, Bruchas MR, Zaveri NT, Schulz S. Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists. Sci Signal. 2019 Mar 26;12(574). pii: eaau8072. doi: 10.1126/scisignal.aau8072. PubMed PMID: 30914485; PubMed Central PMCID: PMC6934085.

Toll L, Bruchas MR, Calo' G, Cox BM, Zaveri NT. Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems. Pharmacol Rev. 2016 Apr;68(2):419-57. doi: 10.1124/pr.114.009209. Epub 2016 Mar 8. Review. PubMed PMID: 26956246; PubMed Central PMCID: PMC4813427.

Recently viewed